 Forest Laboratories Inc. is in the final stages of negotiations to buy specialty pharmaceutical company Aptalis Holdings Inc. for roughly $3 billion, said people familiar with the matter.. Forest's board was meeting Tuesday night and was expected to approve the deal, one of the people said. An announcement could come as soon as Wednesday, this person said.. Private-equity...
  